Cyrus Harmon
Director · 4 filings · Latest: Jul 23, 2026
Olema Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
OLMA | Cyrus Harmon | Director | Jul 24, 2026 | Sale | $11.71 | 12,500 | $146.4K | 702,770 | |
OLMA | Cyrus Harmon | Director | Jul 23, 2026 | Sale | $11.58 | 12,500 | $144.7K | 715,270 | |
OLMA | Harmon Cyrus | — | Jul 24, 2026 | Proposed Sale | $11.71 | 12,500 | $146.4K | — | |
OLMA | Harmon Cyrus | — | Jul 23, 2026 | Proposed Sale | $11.58 | 12,500 | $144.7K | — | |
OLMA | Cyrus Harmon | Director | Jan 20, 2026 | Sale | $26.88 | 10,000 | $268.8K | 727,770 | |
OLMA | Harmon Cyrus | — | Jan 20, 2026 | Proposed Sale | $26.88 | 10,000 | $268.8K | — | |
OLMA | Cyrus Harmon | Director | Jan 14, 2026 | Sale | $29.12 | 3,489 | $101.6K | 737,770 | |
OLMA | Harmon Cyrus | — | Jan 14, 2026 | Proposed Sale | $29.12 | 3,489 | $101.6K | — | |
OLMA | Harmon Cyrus | — | Dec 22, 2025 | Proposed Sale | $28.53 | 2,881 | $82.2K | — | |
OLMA | Harmon Cyrus | — | Sep 18, 2025 | Proposed Sale | $8.33 | 13,086 | $109.0K | — | |
OLMA | Harmon Cyrus | — | Sep 16, 2025 | Proposed Sale | $8.04 | 11,914 | $95.8K | — | |
OLMA | Harmon Cyrus | — | Dec 11, 2024 | Proposed Sale | $8.68 | 8,137 | $70.6K | — | |
OLMA | Harmon Cyrus | — | Dec 10, 2024 | Proposed Sale | $9.37 | 8,256 | $77.4K | — |